News
Today, the value of this approach is widely recognised even by most pharmaceutical companies, a number of which – including Sanofi, Roche and Genentech, Bayer, and Merck KgaA – have partnered with ...
With additional patient-centric data, compute power, and an exciting new focus for its Bayer collaboration, the company is accelerating the shift of biotech to techbioSALT LAKE CITY, Nov. 09, 2023 ...
10d
Interesting Engineering on MSNMIT’s next-gen AI screens millions of molecules at supercomputer speed for drug study
Trained on Recursion’s BioHive-2 and accelerated by NVIDIA, the model achieves near-FEP accuracy at speeds up to 1,000× faster, marking one of the most significant advances yet in AI-enabled drug ...
Recursion releases open-source data from largest ever dataset of biological images and a machine learning competition available through NeurIPS 2019.
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data Growing interest in AI-powered drug discovery draws some big investors–and regulatory questions ...
Salt Lake City, UT, April 22, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results